Clinical Trial Update: Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated safety and preliminary effectiveness of BGB-A445 in combination with tislelizumab in participants with advanced solid tumors, inclu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Nasopharyngeal Carcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• BGB-A445
• Tislelizumab (tislelizumab)

Snippet

Sponsor: BeiGene | Conditions: Advanced Solid Tumor, Non Small Cell Lung Cancer | Phase 1 | Status: COMPLETED